The Innovation and Technology Payment for 2019/20 is open! Here’s what to expect…
Launched at the NHS Innovation Expo 2018 earlier this month, NHS England has developed the Innovation and Technology Payment (ITP) 2019-20.
Delivered with the support of the Academic Health Science Networks (AHSNs), the ITP aims to deliver on the commitment detailed within the Five Year Forward View – supporting the NHS to adopt innovative market-ready medical devices, diagnostics, digital platforms and technologies which have demonstrated improvement to the quality and efficiency of patient care, by removing financial or procurement barriers to uptake.
Here’s what you need to know about the programme:
The Innovation and Technology Payment (ITP) 2019/20 builds on the Innovation and Technology Tariff (ITT) and ITP 2018/19. It aims to support the NHS in adopting innovation by removing some of the financial or procurement barriers which can inhibit uptake at scale.
It is a competitive process designed to scale up adoption of innovations and technologies that have already proved their clinical effectiveness and are ready for nationwide spread.
The ITP is looking to support medical devices, digital platforms and technologies. The programme is not suitable for pharmaceutical products or research projects.
We aim to select a range of cost effective innovations within our budgetary confines in order to have a wide-reaching impact on patient care, and maximise learning from the programme while fostering culture change.
The ITP programme forms part of a wider set of activities to support innovation in the NHS, led by NHS England with the Academic Health Science Networks (AHSNs).
The programme will be delivered with the support of the AHSNs.
The ITP is specifically focused on low cost innovations which can deliver significant patient outcomes and savings to the NHS.
Applicants can be from healthcare, academia, commercial or voluntary sectors.
The implementation of any agreed payment mechanism or procurement will be operational from April 2019.
Day-to-day support and reporting will be via NHS England’s Innovation and Research Unit.